Cas:81528-71-4 N’-(2-methylquinolin-4-yl)ethane-1,2-diamine manufacturer & supplier

We serve Chemical Name:N’-(2-methylquinolin-4-yl)ethane-1,2-diamine CAS:81528-71-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N'-(2-methylquinolin-4-yl)ethane-1,2-diamine

Chemical Name:N’-(2-methylquinolin-4-yl)ethane-1,2-diamine
CAS.NO:81528-71-4
Synonyms:N’-(2-methylquinolin-4-yl)ethane-1,2-diamine
Molecular Formula:C12H15N3
Molecular Weight:201.26800
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:383ºC at 760 mmHg
Density:1.165g/cm3
Index of Refraction:1.673
PSA:50.94000
Exact Mass:201.12700
LogP:2.68710

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N’-(2-methylquinolin-4-yl)ethane-1,2-diamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N’-(2-methylquinolin-4-yl)ethane-1,2-diamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N’-(2-methylquinolin-4-yl)ethane-1,2-diamine Use and application,N’-(2-methylquinolin-4-yl)ethane-1,2-diamine technical grade,usp/ep/jp grade.


Related News: At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. N’-(2-methylquinolin-4-yl)ethane-1,2-diamine manufacturer Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding. N’-(2-methylquinolin-4-yl)ethane-1,2-diamine supplier The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk. N’-(2-methylquinolin-4-yl)ethane-1,2-diamine vendor Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding. N’-(2-methylquinolin-4-yl)ethane-1,2-diamine factory At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.